Q
QuantAbundance

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,677 signal articles · 42 in last 24h · 156,109 total before filter · latest 1h ago
42last 24h
853last 7d
150● bullish (7d)
86● bearish (7d)
214publishers
AllMacro189Earnings112M&A124Regulatory20Product19Analyst21
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Klaviyo, Inc. (KVYO) Meets Q2 Earnings Estimates
Zacks52d agoneutral
Klaviyo, Inc. (KVYO) Meets Q2 Earnings Estimates

Klaviyo, Inc. (KVYO) delivered earnings and revenue surprises of 0.00% and +2.50%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Pfizer (PFE) Could Be 12% Undervalued Following Raised 2026 Revenue Guidance
Simply Wall St.52d agoneutral
Pfizer (PFE) Could Be 12% Undervalued Following Raised 2026 Revenue Guidance

Pfizer (PFE) is back in focus after its second quarter 2026 update, which paired a reported net loss and sizeable non cash impairments with higher full year revenue guidance and solid non COVID product performance. See our latest analysis for Pfizer. The latest results and raised revenue guidance have lifted sentiment toward Pfizer, with the stock showing a 1 month share price return of 8.81% and a 1 year total shareholder return of 15.42%, although longer term total shareholder returns...

DoorDash Q2 Earnings Call Highlights
MarketBeat52d agoneutral
DoorDash Q2 Earnings Call Highlights

DoorDash (NASDAQ:DASH) executives said the company’s Q2 2026 performance reflected continued growth in restaurant delivery, grocery and retail, international operations and subscription adoption, while improved unit economics supported profitability and ongoing investment in technology. During the

Clover Health Investments Q2 Earnings Call Highlights
MarketBeat52d agoneutral
Clover Health Investments Q2 Earnings Call Highlights

Clover Health Investments (NASDAQ:CLOV) reported second-quarter results that showed continued Medicare Advantage membership growth alongside profitability, while raising its full-year 2026 outlook across its key financial measures. Chief Executive Officer Andrew Toy said the company views its Clove

Cirrus Logic Q1 Earnings Call Highlights
MarketBeat52d agoneutral
Cirrus Logic Q1 Earnings Call Highlights

Cirrus Logic (NASDAQ:CRUS) reported record fiscal first-quarter revenue of $460 million for the June quarter, up 2% sequentially and 13% from a year earlier, driven by higher component sales into smartphones. The company posted GAAP earnings per share of $1.47 and non-GAAP earnings per share of $1.8